Winner Profile
Said Darwazah


CEO, Hikma Pharmaceuticals

Industry: Pharmaceuticals

Company size: Large
Published: 2017-07-24

Is Hikma Pharmaceuticals a good stock investment?

Obermatt Stock Research Hikma Pharmaceuticals

 

Based on the annual Obermatt CEO of the Year analysis, Said Darwazah (Hikma Pharmaceuticals) earned the following Obermatt pins for the management performance.

Obermatt accolades Said Darwazah

Said Darwazah was included in the competition among UK 200 Ranking (United Kingdom) (current winners). See the winners of the other competitions or how the CEOs performed over all competitions.

Performance Overview Said Darwazah

In summary, Said Darwazah obtained the following achievements in the individual Obermatt categories by participating in the Obermatt rankings (averages of all evaluated rankings are shown for this CEO, also for other companies):


CEO performance is displayed relative to that of other CEOs that competed in the same categories for the same number of competitions. A ranking of 73 in Combined Performance indicates that Said Darwazah was better than 73% of all other CEOs that were analyzed as part of the UK 200 Ranking – United Kingdom for 5 participations in Obermatt CEO competitions. Said Darwazah’s average ranking can be found in the Multi-Year Rankings for UK 200 Ranking - United Kingdom.